BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 11002254)

  • 1. Polymorphism analysis of Epstein-Barr virus isolates from patients with cutaneous natural killer/T-cell lymphoproliferative disorders: A possible relation to the endemic occurrence of these diseases in Japan.
    Xu ZG; Iwatsuki K; Ohtsuka M; Oyama N; Matsui T; Kaneko F
    J Med Virol; 2000 Oct; 62(2):239-46. PubMed ID: 11002254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus (EBV) subtype in EBV related oral squamous cell carcinoma in Okinawa, a subtropical island in southern Japan, compared with Kitakyushu and Kumamoto in mainland Japan.
    Higa M; Kinjo T; Kamiyama K; Iwamasa T; Hamada T; Iyama K
    J Clin Pathol; 2002 Jun; 55(6):414-23. PubMed ID: 12037022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas.
    Xu ZG; Iwatsuki K; Oyama N; Ohtsuka M; Satoh M; Kikuchi S; Akiba H; Kaneko F
    Br J Cancer; 2001 Apr; 84(7):920-5. PubMed ID: 11286472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Epstein-Barr virus genotype in AIDS-related non-Hodgkin's lymphoma.
    Fassone L; Cingolani A; Martini M; Migliaretti G; Oreste PL; Capello D; Gloghini A; Vivenza D; Dolcetti R; Carbone A; Antinori A; Gaidano G; Larocca LM
    AIDS Res Hum Retroviruses; 2002 Jan; 18(1):19-26. PubMed ID: 11804553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus--associated lymphoproliferative disorders and malignant lymphomas.
    Kingma DW; Weiss WB; Jaffe ES; Kumar S; Frekko K; Raffeld M
    Blood; 1996 Jul; 88(1):242-51. PubMed ID: 8704180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
    Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M
    Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletions and single-base mutations within the carboxy-terminal region of the latent membrane protein 1 oncogene in Epstein-Barr virus-related gastric cancers of southern Japan.
    Mori S; Itoh T; Tokunaga M; Eizuru Y
    J Med Virol; 1999 Feb; 57(2):152-8. PubMed ID: 9892400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of a nuclear antigen 2 (EBNA2)-variant Epstein-Barr virus strain in two siblings with fatal lymphoproliferative disease.
    Schuster V; Seidenspinner S; Kreth HW
    J Med Virol; 1996 Jan; 48(1):114-20. PubMed ID: 8825720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP-1) gene and promoter in Hodgkin's disease isolates: selection against EBV variants with mutations in the LMP-1 promoter ATF-1/CREB-1 binding site.
    Sandvej K; Andresen BS; Zhou XG; Gregersen N; Hamilton-Dutoit S
    Mol Pathol; 2000 Oct; 53(5):280-8. PubMed ID: 11091852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus latency patterns in polymorphic lymphoproliferative disorders and lymphomas in immunodeficiency settings: Diagnostic implications.
    Volaric AK; Saleem A; Younes SF; Zhao S; Natkunam Y
    Ann Diagn Pathol; 2024 Jun; 70():152286. PubMed ID: 38447253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No significant association of Epstein-Barr virus infection with invasive breast carcinoma.
    Chu PG; Chang KL; Chen YY; Chen WG; Weiss LM
    Am J Pathol; 2001 Aug; 159(2):571-8. PubMed ID: 11485915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EBNA2 amino acids 3 to 30 are required for induction of LMP-1 and immortalization maintenance.
    Gordadze AV; Onunwor CW; Peng R; Poston D; Kremmer E; Ling PD
    J Virol; 2004 Apr; 78(8):3919-29. PubMed ID: 15047808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of a 30-base pair deletion in the latent membrane protein-1 gene in Epstein-Barr virus-associated lymphomas in Japan.
    Hirose Y; Masaki Y; Kurose N
    Int J Hematol; 2000 Aug; 72(2):210-5. PubMed ID: 11039671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A20 (TNFAIP3) deletion in Epstein-Barr virus-associated lymphoproliferative disorders/lymphomas.
    Ando M; Sato Y; Takata K; Nomoto J; Nakamura S; Ohshima K; Takeuchi T; Orita Y; Kobayashi Y; Yoshino T
    PLoS One; 2013; 8(2):e56741. PubMed ID: 23418597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense oligodeoxynucleotides to latent membrane protein 1 induce growth inhibition, apoptosis and Bcl-2 suppression in Epstein-Barr virus (EBV)-transformed B-lymphoblastoid cells, but not in EBV-positive natural killer cell lymphoma cells.
    Noguchi T; Ikeda K; Yamamoto K; Yoshida I; Ashiba A; Tsuchiyama J; Shinagawa K; Yoshino T; Takata M; Harada M
    Br J Haematol; 2001 Jul; 114(1):84-92. PubMed ID: 11472349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence variation in the Epstein-Barr virus latent membrane protein 1.
    Miller WE; Edwards RH; Walling DM; Raab-Traub N
    J Gen Virol; 1994 Oct; 75 ( Pt 10)():2729-40. PubMed ID: 7931159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of Epstein-Barr virus latency type III at the single cell level in post-transplantation lymphoproliferative disorders and AIDS related lymphomas.
    Brink AA; Dukers DF; van den Brule AJ; Oudejans JJ; Middeldorp JM; Meijer CJ; Jiwa M
    J Clin Pathol; 1997 Nov; 50(11):911-8. PubMed ID: 9462239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus DNA and latent gene products in Ki-1 (CD30)-positive anaplastic large cell lymphomas.
    Herbst H; Dallenbach F; Hummel M; Niedobitek G; Finn T; Young LS; Rowe M; Müller-Lantzsch N; Stein H
    Blood; 1991 Nov; 78(10):2666-73. PubMed ID: 1668608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of latent membrane proteins (LMP) of Epstein-Barr virus in malignant lymphomas].
    Herbst H; Dallenbach F; Niedobitek G; Anagnostopoulos I; Hummel M; Finn T; Jautzke G; Müller-Lantzsch N; Stein H
    Verh Dtsch Ges Pathol; 1991; 75():175-8. PubMed ID: 1724825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in EBNA2 and LMP-1 carboxy terminal region sequences of Epstein-Barr virus type A between the tumors in a multiple cancer patient.
    Higa M; Kinjo T; Miyagi J; Sakumoto N; Iwamasa T; Kishaba M; Sunakawa H
    Pathol Res Pract; 2001; 197(6):401-9. PubMed ID: 11432667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.